Company intelligence / Profile preview

Vivatinell

Ownership: Private
Development stage: Commercial

Overview

Vivatinell offers over 200 evidence-based consumer healthcare products under 12 brands across 37 countries. Their approach emphasizes personalization and prevention for everyday health challenges. No clinical trial data reported; focus on consumer product efficacy and satisfaction.

Therapeutic areas: OtherPreventive MedicineMetabolic DisordersDermatology
Modalities: Non-pharmacological therapyDevice (e.g., personal care devices)NutraceuticalsSupplements
Industry: Food & Nutrition

Drug pipeline

2 assets

Diabest

Commercial

Indications: Diabetes

1 more asset in the full pipeline.

Request access →

Partnerships

Works with global distribution partners in over 30 countries

Beyond the preview

Go deeper on Vivatinell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivatinell.

Explore the full profile